|
Toll Free: (877) 796-6397 -- USA and Canada only -- |
Fax: +1-832-582-8590 Orders: +1-832-582-8158 |
Tech Support: +1-832-582-8158 Ext:3 Please provide your Order Number in the email. |
Technical Data
| CAS No. | 945721-28-8 |
|---|---|
| Formulation | PBS Buffer, PH 7.4 |
| Isotype | Human IgG1 |
| Source | Human |
| Storage (From the date of receipt) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles |
| Purity | 98.74% |
| Protein concentration | 5.09mg/ml |
| Endotoxin Level | ≤1 EU/mg |
Biological Activity
| Description | Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa. |
|---|
Selleck's Daratumumab (anti-CD38) has been cited by 3 publications
| In vitro testing of drug response in primary multiple myeloma cells using a microwell-based technology [ Leuk Res, 2024, 147:107599] | PubMed: 39486120 |
| Characterising how a single bout of exercise in people with myeloma affects clonal plasma cell and immune effector cell frequency in blood, and daratumumab efficacy in vitro [ Brain Behav Immun Health, 2024, 42:100865] | PubMed: 39411424 |
| Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphoma [ J Exp Med, 2022, 219(9)e20220214] | PubMed: 35881112 |
FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS.
Specific storage and handling information for each product is indicated on the product datasheet. Most Selleck products are stable under the recommended conditions. Products are sometimes shipped at a temperature that differs from the recommended storage temperature. Short-term storage of many products are stable in the short-term at temperatures that differ from that required for long-term storage.
We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt of the product, follow the storage recommendations on the product data sheet.